MEDIUM confidence: 100% data completeness, but the composite (53) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $83 avg across 9 analysts.
Buy-rated share 27% → 20% over ~3 months (-7pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | $1.23 | $1.28 | +4.1% |
| Mar 2026 | $2.46 | $2.61 | +6.1% |
| Nov 2025 | $1.31 | $1.40 | +6.9% |
| Aug 2025 | $1.21 | $1.28 | +5.8% |
| May 2025 | $1.10 | $1.15 | +4.5% |
| Mar 2025 | $2.41 | $2.58 | +7.1% |
| Nov 2024 | $1.30 | $1.26 | -3.1% |
| Aug 2024 | $1.16 | $1.34 | +15.5% |
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $51.8B— | $46.3B-10.6% | $43.5B-6.1% | $41.5B-4.4% | $41.7B+0.4% |
| EPS (dil.) | $9.84— | $6.29-36.1% | $5.68-9.7% | $4.28-24.6% | $5.04+17.8% |
| Free Cash Flow | $2.5B— | $894M-64.5% | $675M-24.5% | $1.4B+106.2% | $1.3B-9.6% |
| Gross Margin | 22.5% | 21.4%-1.1pp | 22.1%+0.7pp | 22.6%+0.5pp | 22.5%-0.1pp |
| Operating Margin | 5.8% | 3.9%-1.9pp | 3.6%-0.3pp | 4.2%+0.6pp | 4.2%+0.0pp |
| Net Margin | 4.7% | 3.1%-1.7pp | 2.9%-0.2pp | 2.2%-0.6pp | 2.6%+0.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$156.2M over 180 days (0 open-market buys, 22 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 1.2%/yr (revenue basis).
Base free cash flow $1.1B (avg FY2024–FY2026; latest year $1.3B) · equity value $17.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 53 for BBY indicates a neutral outlook, driven by a mix of positive and negative factors. The stock scores high on momentum, with a 12-month return of 21.1% and a bullish 50-day versus 200-day moving average crossover. However, its growth and profitability scores are lower, due to slow revenue growth of 0.4% and a decline in free cash flow growth of -9.6%. The long-term and short-term scores are relatively aligned, with only a 4-point difference, suggesting a consistent outlook.